
FDA Approves New Drug for Thyroid Eye Disease Patients
People with thyroid eye disease now have a powerful new treatment option that works for both active and chronic forms of the condition. The FDA just approved veligrotug, offering fresh hope to patients who've struggled with bulging eyes and double vision.
















